Green Oaks, IL, United States of America

Steven G Spanton

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven G Spanton. Retrieved from https://idiyas.com/inventor/steven-g-spanton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Steven G. Spanton

Introduction

Steven G. Spanton is an accomplished inventor based in Green Oaks, Illinois. He is known for his contributions to the field of pharmaceuticals, particularly in the development of novel antibiotics. His work has led to significant advancements in therapeutic agents.

Latest Patents

Steven G. Spanton holds 1 patent for his invention titled "Crystal form I of clarithromycin." This patent concerns the novel antibiotic 6-O-methylerythromycin A crystal form I, detailing a process for its preparation, pharmaceutical compositions comprising this compound, and a method of use as a therapeutic agent.

Career Highlights

Steven is currently employed at Abbott Laboratories Corporation, a leading global healthcare company. His role involves research and development in the pharmaceutical sector, where he applies his expertise to create innovative solutions for health challenges.

Collaborations

Throughout his career, Steven has collaborated with notable colleagues, including Jih-Hua Liu and David A. Riley. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Steven G. Spanton's contributions to the field of pharmaceuticals exemplify the impact of innovation in healthcare. His work continues to influence the development of effective therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…